2013 San Antonio Breast Cancer Symposium

Education and new research to improve and refine treatments and improve quality of life is presented each December at the San Antonio Breast Cancer Symposium, the largest research meeting of its kind. Here are some of the findings and resources from December 2013.

Here are my notes on a talk by Hal Burstein, oncologist and researcher from Dana Farber Cancer Institute, who shared his perspective on the treatment of hormone-responsive (HR+ or also called ER+) metastatic breast cancer.  

My notes on a talk from Lisa Carey, oncologist and researcher from the University of North Carolina, who shared her perspectives on the management of triple negative metastatic breast cancer, and the emerging research.